UB Paderborn / Katalog / Suche / in CDI

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002478

2021

Link zum Volltext

Verfügbarkeit prüfen

Herpes Labialis and Facial-Nerve Paralysis

The New England journal of medicine, 2014-03, Vol.370 (11), p.1048-1048

2014

Link zum Volltext

Verfügbarkeit prüfen

Blurry Vision as a Presentation of Waldenström’s Macroglobulinemia: A Case Report With Review of Current Management

JIM - high impact case reports, 2022-01, Vol.10, p.23247096211052187-23247096211052187

2022

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobin SO-Arab and α-Thalassemia Diagnosed in an Adult: A Case-based Review of the Hemoglobinopathies

The American journal of the medical sciences, 2013-10, Vol.346 (4), p.325-327

2013

Link zum Volltext

Verfügbarkeit prüfen

A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer

The American journal of the medical sciences, 2012-08, Vol.344 (2), p.147-150

2012

Link zum Volltext

Verfügbarkeit prüfen

Forgotten Histories

The oncologist (Dayton, Ohio), 2011, Vol.16 (4), p.537-538

Boulmay, Brian C.

2011

Link zum Volltext

Verfügbarkeit prüfen

A Difficult Task: Determining Oral Anticoagulation Efficacy (OAC) in Patients with HIT Type II

Blood, 2022-11, Vol.140 (Supplement 1), p.11356-11357

2022

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant High‐Dose Interferon‐α for Resected Melanoma in a Patient with HIV Infection

The oncologist (Dayton, Ohio), 2010-07, Vol.15 (7), p.695-698

2010

Link zum Volltext

Verfügbarkeit prüfen

Restoration of medical oncology services at LSU Interim Public Hospital in New Orleans after Hurricane Katrina: a two-year experience of LSUHSC

The Journal of the Louisiana State Medical Society, 2011-05, Vol.163 (3), p.144

2011

Link zum Volltext

Verfügbarkeit prüfen

Mo1460 – Hepatocellular Carcinoma (HCC) Outcomes in an Ethnically Diverse Population: Data from University Medical Center in New Orleans

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1314-S-1314

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of immune checkpoint inhibitors (ICI) and venous thromboembolism (VTE): A single healthcare system experience

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e14567-e14567

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of immune checkpoint inhibitors (ICI) and venous thromboembolism (VTE) in non–small-cell lung cancer (NSCLC): A single healthcare system experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14680-e14680

2023

Link zum Volltext

Verfügbarkeit prüfen

Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer

American journal of clinical oncology, 2009-10, Vol.32 (5), p.488-491

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessing Immune Response to 3rd Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans

Blood, 2022-11, Vol.140 (Supplement 1), p.13154-13155

2022

Link zum Volltext

Verfügbarkeit prüfen

A 32-year-old woman with chest pain, hematemesis, and thrombocytopenia

The Journal of the Louisiana State Medical Society, 2009-05, Vol.161 (3), p.130

2009

Link zum Volltext

Verfügbarkeit prüfen

BXQ-350: A phase 1b/2 placebo controlled, double blinded study on the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma (mCRC)

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS224-TPS224

2024

Link zum Volltext

Verfügbarkeit prüfen

Improved hepatocellular carcinoma (HCC) outcomes in a public hospital setting with increased access to procedural-based therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18137-e18137

2019

Link zum Volltext

Verfügbarkeit prüfen

Adequacy of lung cancer tissue samples for ancillary molecular testing in conventionally obtained biopsy material: A 3-year experience of the Louisiana State University (LSU) public hospital in New Orleans

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.105-105

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma (HCC) outcomes in a public hospital setting: Characteristics and outcomes from the Interim LSU Public Hospital (ILH) in New Orleans

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17533-e17533

2015

Link zum Volltext

Verfügbarkeit prüfen

A 28-year-old man with leukocytosis and anemia

The Journal of the Louisiana State Medical Society, 2010-01, Vol.162 (1), p.8

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of aldoxorubicin in relapsed glioblastoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2027-2027

2016

Link zum Volltext

Verfügbarkeit prüfen

Head and neck cancer (HN) characteristics and outcomes in a human immunodeficiency virus infected (HIV+) patient cohort: A 12-year experience of the Louisiana State University Health Sciences Center (LSUHSC) and Charity Hospital in New Orleans

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6069-6069

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of absence of in-house radiation facilities for patients (pts) treated with concurrent chemoradiotherapy (CCRT) for locally advanced head and cancer (LAHNC): A 3-year public hospital (PH) experience at Louisiana State University (LSU) in New Orleans

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e17523-e17523

2014

Link zum Volltext

Verfügbarkeit prüfen

Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9506-9506

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Herpes Labialis and Facial-Nerve Paralysis

Blurry Vision as a Presentation of Waldenström’s Macroglobulinemia: A Case Report With Review of Current Management

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Hemoglobin SO-Arab and α-Thalassemia Diagnosed in an Adult: A Case-based Review of the Hemoglobinopathies

A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer

Forgotten Histories

A Difficult Task: Determining Oral Anticoagulation Efficacy (OAC) in Patients with HIT Type II

Adjuvant High‐Dose Interferon‐α for Resected Melanoma in a Patient with HIV Infection

Restoration of medical oncology services at LSU Interim Public Hospital in New Orleans after Hurricane Katrina: a two-year experience of LSUHSC

Mo1460 – Hepatocellular Carcinoma (HCC) Outcomes in an Ethnically Diverse Population: Data from University Medical Center in New Orleans

Association of immune checkpoint inhibitors (ICI) and venous thromboembolism (VTE): A single healthcare system experience

Association of immune checkpoint inhibitors (ICI) and venous thromboembolism (VTE) in non–small-cell lung cancer (NSCLC): A single healthcare system experience

Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer

Assessing Immune Response to 3rd Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans

A 32-year-old woman with chest pain, hematemesis, and thrombocytopenia

BXQ-350: A phase 1b/2 placebo controlled, double blinded study on the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma (mCRC)

Improved hepatocellular carcinoma (HCC) outcomes in a public hospital setting with increased access to procedural-based therapy

Adequacy of lung cancer tissue samples for ancillary molecular testing in conventionally obtained biopsy material: A 3-year experience of the Louisiana State University (LSU) public hospital in New Orleans

Hepatocellular carcinoma (HCC) outcomes in a public hospital setting: Characteristics and outcomes from the Interim LSU Public Hospital (ILH) in New Orleans

A 28-year-old man with leukocytosis and anemia

Phase 2 study of aldoxorubicin in relapsed glioblastoma

Head and neck cancer (HN) characteristics and outcomes in a human immunodeficiency virus infected (HIV+) patient cohort: A 12-year experience of the Louisiana State University Health Sciences Center (LSUHSC) and Charity Hospital in New Orleans

Impact of absence of in-house radiation facilities for patients (pts) treated with concurrent chemoradiotherapy (CCRT) for locally advanced head and cancer (LAHNC): A 3-year public hospital (PH) experience at Louisiana State University (LSU) in New Orleans

Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy

Suchergebnisse filtern